Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 8;11(3):356.
doi: 10.3390/antibiotics11030356.

Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens

Álvaro Mourenza  1 , Blanca Lorente-Torres  1 , Elena Durante  1   2 , Jesús Llano-Verdeja  1 , Jesús F Aparicio  1 , Arsenio Fernández-López  3   4   5 , José A Gil  1   6 , Luis M Mateos  1   6 , Michal Letek  1   7
Affiliations
Review

Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens

Álvaro Mourenza et al. Antibiotics (Basel). .

Abstract

The development of RNA-based anti-infectives has gained interest with the successful application of mRNA-based vaccines. Small RNAs are molecules of RNA of <200 nucleotides in length that may control the expression of specific genes. Small RNAs include small interference RNAs (siRNAs), Piwi-interacting RNAs (piRNAs), or microRNAs (miRNAs). Notably, the role of miRNAs on the post-transcriptional regulation of gene expression has been studied in detail in the context of cancer and many other genetic diseases. However, it is also becoming apparent that some human miRNAs possess important antimicrobial roles by silencing host genes essential for the progress of bacterial or viral infections. Therefore, their potential use as novel antimicrobial therapies has gained interest during the last decade. The challenges of the transport and delivery of miRNAs to target cells are important, but recent research with exosomes is overcoming the limitations in RNA-cellular uptake, avoiding their degradation. Therefore, in this review, we have summarised the latest developments in the exosomal delivery of miRNA-based therapies, which may soon be another complementary treatment to pathogen-targeted antibiotics that could help solve the problem caused by multidrug-resistant bacteria.

Keywords: antimicrobial; bacteria; infection; miRNAs; pathogen.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Exosomal delivery of antimicrobial miRNAs to infected cells. Created with BioRender.com (accessed on 1 February 2022).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993;75:855–862. doi: 10.1016/0092-8674(93)90530-4. - DOI - PubMed
    1. Treiber T., Treiber N., Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat. Rev. Mol. Cell Biol. 2019;20:5–20. doi: 10.1038/s41580-018-0059-1. - DOI - PubMed
    1. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136:642–655. doi: 10.1016/j.cell.2009.01.035. - DOI - PMC - PubMed
    1. Kim J.K., Kim T.S., Basu J., Jo E.K. MicroRNA in innate immunity and autophagy during mycobacterial infection. Cell. Microbiol. 2017;19:e12687. doi: 10.1111/cmi.12687. - DOI - PubMed
    1. Eulalio A., Schulte L.N., Voge J. The mammalian microRNA response to bacterial infections. RNA Biol. 2012;9:742–750. doi: 10.4161/rna.20018. - DOI - PubMed

LinkOut - more resources